Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01461954 · ClinicalTrials.gov registry record · Phase 2
FST-100 in the Treatment of Acute Viral Conjunctivitis
A Phase 2 study, sponsored by Shire.
- Completed
- Registry status
- Phase 2
- Development phase
- 132
- Enrollment target
NCT01461954 is a Phase 2 study that has completed, run by Shire. The registered enrollment target is 132 participants.
The verdict
NCT01461954, a Phase 2 study, has completed, sponsored by Shire.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 132 participants
- Enrollment target
Study Summary
This randomized, double masked, multi-center study is being conducted to support the safety and efficacy of FST-100 for the treatment of acute viral conjunctivitis. The study intends to show superiority of FST-100 ophthalmic suspension compared to vehicle for clinical resolution of acute viral conjunctivitis.
Interventions
- DRUG FST-100
- DRUG FST-100 Vehicle
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 132 participants |
| Start Date | 2013-05-17 |
| Est. Completion | 2014-03-10 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01461954
The ClinicalTrials.gov registry entry for NCT01461954 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 132 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Shire, which has 245 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which FST-100 is the first listed.
NCT01461954 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01461954 about?
NCT01461954 is a clinical study titled "FST-100 in the Treatment of Acute Viral Conjunctivitis". This randomized, double masked, multi-center study is being conducted to support the safety and efficacy of FST-100 for the treatment of acute viral conjunctivitis. The study intends to show superiority of FST-100 ophthalmic suspension compared to vehicle for clinical resolution of acute viral conju...
What is the current status of trial NCT01461954?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 132 participants. The study started on 2013-05-17. Estimated completion is 2014-03-10.
What interventions are being tested in trial NCT01461954?
The interventions under investigation include: FST-100 (DRUG), FST-100 Vehicle (DRUG).
Who is sponsoring clinical trial NCT01461954?
This trial is sponsored by Shire, which has 245 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.